Inflammation-mediated fibroblast activation and immune dysregulation in collagen VII-deficient skin

Inflammation is known to play a critical role in all stages of tumorigenesis; however, less is known about how it predisposes the tissue microenvironment preceding tumor formation. Recessive dystrophic epidermolysis bullosa (RDEB), a skin-blistering disease secondary to COL7A1 mutations and associat...

Full description

Bibliographic Details
Main Authors: Morgan Anderson-Crannage, Alex M. Ascensión, Olga Ibanez-Solé, Hongwen Zhu, Edo Schaefer, Darcy Ottomanelli, Bruno Hochberg, Jian Pan, Wen Luo, Meijuan Tian, Yaya Chu, Mitchell S. Cairo, Ander Izeta, Yanling Liao
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1211505/full
_version_ 1827808849398071296
author Morgan Anderson-Crannage
Morgan Anderson-Crannage
Alex M. Ascensión
Olga Ibanez-Solé
Hongwen Zhu
Edo Schaefer
Darcy Ottomanelli
Bruno Hochberg
Jian Pan
Wen Luo
Meijuan Tian
Yaya Chu
Mitchell S. Cairo
Mitchell S. Cairo
Mitchell S. Cairo
Mitchell S. Cairo
Ander Izeta
Ander Izeta
Yanling Liao
author_facet Morgan Anderson-Crannage
Morgan Anderson-Crannage
Alex M. Ascensión
Olga Ibanez-Solé
Hongwen Zhu
Edo Schaefer
Darcy Ottomanelli
Bruno Hochberg
Jian Pan
Wen Luo
Meijuan Tian
Yaya Chu
Mitchell S. Cairo
Mitchell S. Cairo
Mitchell S. Cairo
Mitchell S. Cairo
Ander Izeta
Ander Izeta
Yanling Liao
author_sort Morgan Anderson-Crannage
collection DOAJ
description Inflammation is known to play a critical role in all stages of tumorigenesis; however, less is known about how it predisposes the tissue microenvironment preceding tumor formation. Recessive dystrophic epidermolysis bullosa (RDEB), a skin-blistering disease secondary to COL7A1 mutations and associated with chronic wounding, inflammation, fibrosis, and cutaneous squamous cell carcinoma (cSCC), models this dynamic. Here, we used single-cell RNA sequencing (scRNAseq) to analyze gene expression patterns in skin cells from a mouse model of RDEB. We uncovered a complex landscape within the RDEB dermal microenvironment that exhibited altered metabolism, enhanced angiogenesis, hyperproliferative keratinocytes, infiltration and activation of immune cell populations, and inflammatory fibroblast priming. We demonstrated the presence of activated neutrophil and Langerhans cell subpopulations and elevated expression of PD-1 and PD-L1 in T cells and antigen-presenting cells, respectively. Unsupervised clustering within the fibroblast population further revealed two differentiation pathways in RDEB fibroblasts, one toward myofibroblasts and the other toward a phenotype that shares the characteristics of inflammatory fibroblast subsets in other inflammatory diseases as well as the IL-1-induced inflammatory cancer-associated fibroblasts (iCAFs) reported in various cancer types. Quantitation of inflammatory cytokines indicated dynamic waves of IL-1α, TGF-β1, TNF, IL-6, and IFN-γ concentrations, along with dermal NF-κB activation preceding JAK/STAT signaling. We further demonstrated the divergent and overlapping roles of these cytokines in inducing inflammatory phenotypes in RDEB patients as well as RDEB mouse-derived fibroblasts together with their healthy controls. In summary, our data have suggested a potential role of inflammation, driven by the chronic release of inflammatory cytokines such as IL-1, in creating an immune-suppressed dermal microenvironment that underlies RDEB disease progression.
first_indexed 2024-03-11T22:34:40Z
format Article
id doaj.art-34e1d4686234451eb208aeefa7d3b96f
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-11T22:34:40Z
publishDate 2023-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-34e1d4686234451eb208aeefa7d3b96f2023-09-22T19:01:57ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-09-011410.3389/fimmu.2023.12115051211505Inflammation-mediated fibroblast activation and immune dysregulation in collagen VII-deficient skinMorgan Anderson-Crannage0Morgan Anderson-Crannage1Alex M. Ascensión2Olga Ibanez-Solé3Hongwen Zhu4Edo Schaefer5Darcy Ottomanelli6Bruno Hochberg7Jian Pan8Wen Luo9Meijuan Tian10Yaya Chu11Mitchell S. Cairo12Mitchell S. Cairo13Mitchell S. Cairo14Mitchell S. Cairo15Ander Izeta16Ander Izeta17Yanling Liao18Department of Pediatrics, New York Medical College, Valhalla, NY, United StatesDepartment of Cell Biology and Anatomy, New York Medical College, Valhalla, NY, United StatesBiodonostia Health Research Institute, Tissue Engineering Group, San Sebastian, SpainBiodonostia Health Research Institute, Tissue Engineering Group, San Sebastian, SpainDepartment of Research & Development, Guizhou Atlasus Technology Co., Ltd., Guiyang, ChinaDepartment of Pediatrics, New York Medical College, Valhalla, NY, United StatesDepartment of Pediatrics, New York Medical College, Valhalla, NY, United StatesDepartment of Pediatrics, New York Medical College, Valhalla, NY, United StatesDepartment of Pediatrics, New York Medical College, Valhalla, NY, United StatesDepartment of Pediatrics, New York Medical College, Valhalla, NY, United StatesDepartment of Pediatrics, New York Medical College, Valhalla, NY, United StatesDepartment of Pediatrics, New York Medical College, Valhalla, NY, United StatesDepartment of Pediatrics, New York Medical College, Valhalla, NY, United StatesDepartment of Cell Biology and Anatomy, New York Medical College, Valhalla, NY, United StatesDepartment of Medicine, New York Medical College, Valhalla, NY, United StatesDepartment of Pathology, Microbiology and Immunology, New York Medical College, Valhalla, NY, United StatesBiodonostia Health Research Institute, Tissue Engineering Group, San Sebastian, SpainDepartment of Biomedical Engineering and Science, School of Engineering, Tecnun University of Navarra, San Sebastian, SpainDepartment of Pediatrics, New York Medical College, Valhalla, NY, United StatesInflammation is known to play a critical role in all stages of tumorigenesis; however, less is known about how it predisposes the tissue microenvironment preceding tumor formation. Recessive dystrophic epidermolysis bullosa (RDEB), a skin-blistering disease secondary to COL7A1 mutations and associated with chronic wounding, inflammation, fibrosis, and cutaneous squamous cell carcinoma (cSCC), models this dynamic. Here, we used single-cell RNA sequencing (scRNAseq) to analyze gene expression patterns in skin cells from a mouse model of RDEB. We uncovered a complex landscape within the RDEB dermal microenvironment that exhibited altered metabolism, enhanced angiogenesis, hyperproliferative keratinocytes, infiltration and activation of immune cell populations, and inflammatory fibroblast priming. We demonstrated the presence of activated neutrophil and Langerhans cell subpopulations and elevated expression of PD-1 and PD-L1 in T cells and antigen-presenting cells, respectively. Unsupervised clustering within the fibroblast population further revealed two differentiation pathways in RDEB fibroblasts, one toward myofibroblasts and the other toward a phenotype that shares the characteristics of inflammatory fibroblast subsets in other inflammatory diseases as well as the IL-1-induced inflammatory cancer-associated fibroblasts (iCAFs) reported in various cancer types. Quantitation of inflammatory cytokines indicated dynamic waves of IL-1α, TGF-β1, TNF, IL-6, and IFN-γ concentrations, along with dermal NF-κB activation preceding JAK/STAT signaling. We further demonstrated the divergent and overlapping roles of these cytokines in inducing inflammatory phenotypes in RDEB patients as well as RDEB mouse-derived fibroblasts together with their healthy controls. In summary, our data have suggested a potential role of inflammation, driven by the chronic release of inflammatory cytokines such as IL-1, in creating an immune-suppressed dermal microenvironment that underlies RDEB disease progression.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1211505/fullepidermolysis bullosainflammationimmune suppressiondermal microenvironmentfibroblast activationinterleukin-1
spellingShingle Morgan Anderson-Crannage
Morgan Anderson-Crannage
Alex M. Ascensión
Olga Ibanez-Solé
Hongwen Zhu
Edo Schaefer
Darcy Ottomanelli
Bruno Hochberg
Jian Pan
Wen Luo
Meijuan Tian
Yaya Chu
Mitchell S. Cairo
Mitchell S. Cairo
Mitchell S. Cairo
Mitchell S. Cairo
Ander Izeta
Ander Izeta
Yanling Liao
Inflammation-mediated fibroblast activation and immune dysregulation in collagen VII-deficient skin
Frontiers in Immunology
epidermolysis bullosa
inflammation
immune suppression
dermal microenvironment
fibroblast activation
interleukin-1
title Inflammation-mediated fibroblast activation and immune dysregulation in collagen VII-deficient skin
title_full Inflammation-mediated fibroblast activation and immune dysregulation in collagen VII-deficient skin
title_fullStr Inflammation-mediated fibroblast activation and immune dysregulation in collagen VII-deficient skin
title_full_unstemmed Inflammation-mediated fibroblast activation and immune dysregulation in collagen VII-deficient skin
title_short Inflammation-mediated fibroblast activation and immune dysregulation in collagen VII-deficient skin
title_sort inflammation mediated fibroblast activation and immune dysregulation in collagen vii deficient skin
topic epidermolysis bullosa
inflammation
immune suppression
dermal microenvironment
fibroblast activation
interleukin-1
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1211505/full
work_keys_str_mv AT morganandersoncrannage inflammationmediatedfibroblastactivationandimmunedysregulationincollagenviideficientskin
AT morganandersoncrannage inflammationmediatedfibroblastactivationandimmunedysregulationincollagenviideficientskin
AT alexmascension inflammationmediatedfibroblastactivationandimmunedysregulationincollagenviideficientskin
AT olgaibanezsole inflammationmediatedfibroblastactivationandimmunedysregulationincollagenviideficientskin
AT hongwenzhu inflammationmediatedfibroblastactivationandimmunedysregulationincollagenviideficientskin
AT edoschaefer inflammationmediatedfibroblastactivationandimmunedysregulationincollagenviideficientskin
AT darcyottomanelli inflammationmediatedfibroblastactivationandimmunedysregulationincollagenviideficientskin
AT brunohochberg inflammationmediatedfibroblastactivationandimmunedysregulationincollagenviideficientskin
AT jianpan inflammationmediatedfibroblastactivationandimmunedysregulationincollagenviideficientskin
AT wenluo inflammationmediatedfibroblastactivationandimmunedysregulationincollagenviideficientskin
AT meijuantian inflammationmediatedfibroblastactivationandimmunedysregulationincollagenviideficientskin
AT yayachu inflammationmediatedfibroblastactivationandimmunedysregulationincollagenviideficientskin
AT mitchellscairo inflammationmediatedfibroblastactivationandimmunedysregulationincollagenviideficientskin
AT mitchellscairo inflammationmediatedfibroblastactivationandimmunedysregulationincollagenviideficientskin
AT mitchellscairo inflammationmediatedfibroblastactivationandimmunedysregulationincollagenviideficientskin
AT mitchellscairo inflammationmediatedfibroblastactivationandimmunedysregulationincollagenviideficientskin
AT anderizeta inflammationmediatedfibroblastactivationandimmunedysregulationincollagenviideficientskin
AT anderizeta inflammationmediatedfibroblastactivationandimmunedysregulationincollagenviideficientskin
AT yanlingliao inflammationmediatedfibroblastactivationandimmunedysregulationincollagenviideficientskin